{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:29:12Z","timestamp":1761895752217},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.acuro.2011.01.008","type":"journal-article","created":{"date-parts":[[2013,9,10]],"date-time":"2013-09-10T01:29:08Z","timestamp":1378776548000},"page":"232-239","source":"Crossref","is-referenced-by-count":11,"title":["P\u00e9rdida de masa \u00f3sea en pacientes con c\u00e1ncer de pr\u00f3stata sometidos a deprivaci\u00f3n androg\u00e9nica"],"prefix":"10.1016","volume":"35","author":[{"given":"J.","family":"Morote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Planas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2011.01.008_bib0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acuro.2011.01.008_bib0010","unstructured":"http:\/\/globocan.iarc.fr\/ [Acceso: 19 de septiembre de 2010]."},{"key":"10.1016\/j.acuro.2011.01.008_bib0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2004.11.070","article-title":"Crosstalk between cancer cells and bone microenvironment in bone metastasis","volume":"328","author":"Yoneda","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.acuro.2011.01.008_bib0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-5347(01)65165-6","article-title":"Osteoporosis after orchiectomy for prostate cancer","volume":"157","author":"Daniell","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<545::AID-CNCR17>3.0.CO;2-3","article-title":"Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma","volume":"79","author":"Townsend","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.acuro.2011.01.008_bib0030","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20955","article-title":"Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma","volume":"103","author":"Shahinian","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.acuro.2011.01.008_bib0035","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1464-410X.2006.06416.x","article-title":"The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study","volume":"98","author":"Barry","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2011.01.008_bib0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.acuro.2011.01.008_bib0045","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1359\/JBMR.041133","article-title":"Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures","volume":"20","author":"Jiang","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.acuro.2011.01.008_bib0050","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/bmj.38643.663843.55","article-title":"Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study","volume":"331","author":"Roche","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.acuro.2011.01.008_bib0055","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-5347(05)64561-2","article-title":"Skeletal fractures negatively correlate with overall survival in men with prostate cancer","volume":"168","author":"Oefelein","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0060","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0302-2838(03)00379-8","article-title":"Osteoporosis during continuous androgen deprivation: influence of the modality and length of treatment","volume":"44","author":"Morote","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0065","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","article-title":"Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"issue":"6 Pt 1","key":"10.1016\/j.acuro.2011.01.008_bib0075","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ju.0000143930.73016.c6","article-title":"Hip fractures in men with prostate cancer treated with orchiectomy","volume":"172","author":"Dickman","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0080","unstructured":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994; 843:1-129."},{"key":"10.1016\/j.acuro.2011.01.008_bib0085","doi-asserted-by":"crossref","unstructured":"Morote J, Planas J, Ravent\u00f3s C, Placer J, Encabo G. Axial versus peripheral DXA scan to asses osteoporosis in prostate cancer patients. J Urol. 2010; 183(4)Suppl335.[AUA, Annual Meeting Proceedings: Abstract 858].","DOI":"10.1016\/j.juro.2010.02.1614"},{"key":"10.1016\/j.acuro.2011.01.008_bib0090","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.juro.2010.02.022","article-title":"Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer","volume":"183","author":"Saylor","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0095","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1464-410X.2003.04471.x","article-title":"Immediate dual energy X-ray absorptiometry reveals a high incidence of osteoporosis in patients with advanced prostate cancer before hormonal manipulation","volume":"92","author":"Hussain","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2011.01.008_bib0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpuro0995","article-title":"Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?","volume":"5","author":"Higano","year":"2008","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0105","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1210\/jc.2005-0183","article-title":"Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer","volume":"90","author":"Greenspan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.acuro.2011.01.008_bib0110","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0022-5347(05)00999-7","article-title":"Bone mineral density changes in patients with prostate cancer during the first 2years of androgen suppression","volume":"175","author":"Morote","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.urology.2006.11.002","article-title":"Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer","volume":"69","author":"Morote","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2011.01.008_bib0120","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1464-410X.2006.06695.x","article-title":"The relationship between daily calcium intake and bone mineral density in men with prostate cancer","volume":"99","author":"Planas","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2011.01.008_bib0125","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.urology.2004.07.019","article-title":"Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression","volume":"64","author":"Higano","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2011.01.008_bib0130","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.2004.01.174","article-title":"Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition","volume":"22","author":"Smith","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0135","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/01.ju.0000063820.94994.95","article-title":"Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0140","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2006.07.3361","article-title":"Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer","volume":"25","author":"Michaelson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acuro.2011.01.008_bib0145","doi-asserted-by":"crossref","first-page":"416","DOI":"10.7326\/0003-4819-146-6-200703200-00006","article-title":"Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acuro.2011.01.008_bib0150","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","article-title":"Denosumab in men receiving androgen-deprivation therapy for prostate cancer","volume":"361","author":"Smith","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuro.2011.01.008_bib0155","unstructured":"National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010."},{"key":"10.1016\/j.acuro.2011.01.008_bib0160","unstructured":"Heidenreich A, Bolla M, Joniau S, Mason MD, Matveev V, Mottet N, et al. 2010. Guidelines on prostate cancer. Disponible en: http:\/\/www.uroweb.org\/guidelines\/online-guidelines\/ [Acceso 19 de septiembre de 2010]."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480611000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480611000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T02:26:20Z","timestamp":1539397580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480611000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0210480611000490"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2011.01.008","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}